Page last updated: 2024-11-02

pamidronate and Skin Neoplasms

pamidronate has been researched along with Skin Neoplasms in 4 studies

Skin Neoplasms: Tumors or cancer of the SKIN.

Research Excerpts

ExcerptRelevanceReference
"To determine the protective effect of apigenin against growth inhibition of normal epithelial human prostatic (PNT2), transgenic adenocarcinoma of mouse prostate (TRAMP-C1) and metastatic melanoma cells (B16F10) in combined treatments with bisphosphonates and ionizing radiation (IR)."3.79Effects of bisphosphonates in combination with ionizing radiation and antioxidants on the growth of prostate and melanoma cells lines. ( Achel, DG; Alcaraz, M; Alcaraz-Saura, M; Olivares, A, 2013)
"Cutaneous melanoma is one of the highly malignant human tumours, due to its tendency to generate early metastases and its resistance to classical chemotherapy."1.32Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells. ( Forsea, AM; Geilen, CC; Müller, C; Orfanos, CE; Riebeling, C, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcaraz, M1
Olivares, A1
Achel, DG1
Alcaraz-Saura, M1
Forsea, AM1
Müller, C1
Riebeling, C1
Orfanos, CE1
Geilen, CC1
Ramadan, KM1
McKenna, KE1
Morris, TC1
Nakaguchi, K1
Furukawa, J1
Shingai, T1
Azama, T1
Yoshioka, S1
Katsumoto, Y1
Morimoto, T1
Okajima, S1
Sue, F1

Other Studies

4 other studies available for pamidronate and Skin Neoplasms

ArticleYear
Effects of bisphosphonates in combination with ionizing radiation and antioxidants on the growth of prostate and melanoma cells lines.
    Anticancer research, 2013, Volume: 33, Issue:8

    Topics: Animals; Antioxidants; Apigenin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modal

2013
Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
    British journal of cancer, 2004, Aug-16, Volume: 91, Issue:4

    Topics: Antimetabolites; Antineoplastic Agents; Cell Cycle; Clodronic Acid; Diphosphonates; Disease Progress

2004
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
    The Lancet. Oncology, 2006, Volume: 7, Issue:11

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bor

2006
[A case of multiple bone metastases from advanced breast cancer effectively treated with pamidronate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide;

1999